California

Who we are

  • February 24, 2025
    A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
  • October 14, 2024
    A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
  • August 23, 2024
    A Dose Escalation Study of AV-380 in Metastatic Cancer Patients With Cachexia
  • July 8, 2024
    Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
  • June 23, 2024
    Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
  • April 24, 2024
    A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
  • April 19, 2024
    Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
  • February 29, 2024
    A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation
  • February 7, 2024
    Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor
  • February 5, 2024
    ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (AMPLIFY-201)